New Preclinical Data for Novel Immunotherapy Bispecific Candidate ALG.APV-527 Presented by Alligator Bioscience and Aptevo Therapeutics

LUND, Sweden and SEATTLE, May 8, 2018 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, and Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on...

from PR Newswire: //https://ift.tt/2I86esn